Could a new drug combo offer better relief for enlarged prostate?
NCT ID NCT06568718
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether adding a drug called Longidaze to the standard treatment tamsulosin helps reduce urinary symptoms in men with an enlarged prostate. 229 men aged 40 and older took part. The combination was given as injections and rectal suppositories over several months, and researchers measured symptom changes using a standard questionnaire.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOWER URINARY TRACT SYMPTOMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
First Saint Petersburg State Medical University named after academician I.P. Pavlov
Saint Petersburg, 197022, Russia
-
LLC "Clinic of Modern Medicine of Dr. Bogorodskaya"
Yaroslavl, 150001, Russia
-
LLC "Krasnodar Medical and Biological Center"
Krasnodar, 350000, Russia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a fluid injection make prostate surgery safer and less bloody?
- Laser vs. traditional: which surgery eases prostate symptoms best?
- Can a two-drug combo better tame prostate trouble?
- Can adjusting drug schedules improve both urinary and sexual outcomes in men with enlarged prostate?
- Laser surgery before radiation may ease urinary troubles in prostate cancer patients
- Soothing sounds and soft lights may ease patient nerves during bladder exams